Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY:COR)

310.04 -1.73 (-0.56%)
Streaming Delayed Price Updated: 10:18 AM EDT, Oct 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
2 Large-Cap Stocks with Exciting Potential and 1 We Find Risky
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for... 
Via StockStory
1 Surging Stock with Exciting Potential and 2 We Find Risky
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
These S&P500 stocks are moving in today's session
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Thursday. 
Via Chartmill
McKesson Stock Shoots To Record High. Shares Of Health Products Giant Show Improved Price Strength
The upgraded RS Rating puts McKesson stock just one point below the 80 RS Rating that The IBD Methodology look for. 
Via Investor's Business Daily
What Does the Market Think About Cencora?
 
Via Benzinga
Looking Into Cencora's Recent Short Interest
 
Via Benzinga
Why Cencora (COR) Stock Is Trading Up Today
Shares of healthcare distributor Cencora (NYSE:COR) jumped 4.5% in the afternoon session after peer company McKesson raised its long-term earnings growth outlook, boosting investor sentiment across the... 
Via StockStory
Topics Artificial Intelligence
Discover which S&P500 stocks are making waves on Tuesday.
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
The Dawn of a New Era: How GLP-1s, AI, and Robotic Surgery Are Reshaping Healthcare and Investment
The healthcare industry is currently experiencing a transformative "golden age," a period marked by an unprecedented surge in scientific breakthroughs and technological advancements. This era is... 
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
Analyst Expectations For Cencora's Future
 
Via Benzinga
3 S&P 500 Stocks to Target This Week
The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innovate and expand, setting themselves up for... 
Via StockStory
Topics Stocks
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
These stocks are moving in today's after hours session
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
From Cencora
Via Business Wire
Earnings Scheduled For August 6, 2025
 
Via Benzinga
Top S&P500 movers in Friday's session
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
What's going on in today's session: S&P500 movers
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday. 
Via Chartmill
2 Safe-and-Steady Stocks Worth Your Attention and 1 We Brush Off
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
Exploring the top movers within the S&P500 index during today's session.
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Here's How Much $100 Invested In Cencora 5 Years Ago Would Be Worth Today
 
Via Benzinga
Health Insurance Providers Stocks Q2 Teardown: Cencora (NYSE:COR) Vs The Rest
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Cencora (NYSE:COR) and the rest... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
3 Market-Beating Stocks to Research Further
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the... 
Via StockStory
These S&P500 stocks are gapping in today's session
Tuesday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
COR Q2 Deep Dive: Specialty Growth, International Headwinds, and Guidance Update
Healthcare distributor Cencora (NYSE:COR) announced better-than-expected revenue in Q2 CY2025, with sales up 8.7% year on year to $80.66 billion. Its non-GAAP profit of $4 per share was 4.2% above... 
Via StockStory
Topics Economy World Trade
Wall Street Recovers, Apple Rallies 6% On $100-Billion Gov Manufacturing Investment: What's Moving Markets Wednesday?
U.S. stocks rebounded sharply on Wednesday, fully erasing last Friday's losses, as upbeat corporate earnings and renewed investor optimism outweighed concerns over escalating trade tensions. 
Via Benzinga
Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook
Cencora reports Q3 sales of $80.66 billion and EPS of $4.00, both above estimates, driven by GLP-1 and specialty drug demand in U.S. markets. 
Via Benzinga
Cencora’s (NYSE:COR) Q2 Sales Top Estimates
Healthcare distributor Cencora (NYSE:COR) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.7% year on year to $80.66 billion. Its non-GAAP profit of $4 per share... 
Via StockStory
Cencora Reports Fiscal 2025 Third Quarter Results
From Cencora
Via Business Wire
What To Expect From Cencora’s (COR) Q2 Earnings
Healthcare distributor Cencora (NYSE:COR) will be announcing earnings results this Wednesday before market open. Here’s what to expect. 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.